Categories AlphaGraphs, Earnings, Finance

Infographic: 360 DigiTech (QFIN) Q3 revenue up 43%; profit jumps

360 DigiTech, Inc. (NASDAQ: QFIN) on Thursday said its third-quarter revenues and earnings increased in double digits, despite the unfavorable market conditions. Shares of the China-based consumer finance company gained about 6% soon after the announcement.

360 DigiTech Q3 2020 earnings infograph

At RMB 3.70 billion ($545.5 million), September-quarter revenues were up 43.4% from the year-ago period. Credit Driven Services and Platform Services increased by 39% and 65%, respectively.

Consequently, adjusted earnings rose to RMB1.29 billion ($189.74 million) or RMB 8.35 per ADS ($1.23 per ADS) from RMB 755.88 million or RMB 5.05 per ADS in the third quarter of 2019. Unadjusted net earnings climbed 63% year-over-year to RMB 7.98 per ADS ($1.18 per ADS).

Commenting on the third-quarter performance, CEO Haisheng Wu said, “Throughout the quarter, we have witnessed continued recovery in consumer demand for credit and further improvement in asset quality. In fact, some key leading indicators of asset quality of our customers are at the best levels ever, a strong testimony for our effective risk management and solid overall execution.”


Read management/analysts’ comments on 360 DigiTech’s Q3 results


The company’s stock gained sharply during Thursday’s extended trading session at the Nasdaq stock exchange, immediately after the announcement. The shares have gained 26% since the beginning of the year.

  • 360 Finance (QFIN) Q1 earnings fall
  • 360 Finance Q4 2019 earnings infographic
  • 360 Finance Q3 2019 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top